Design, synthesis and chemical stability of indolizine derivatives for antidiabetic activity

References

• Kokil, G. R.; Veedu, R. N.; Ramm, G. A.; Prins, J. B.; Parekh, H. S. Type 2 Diabetes Mellitus: Limitations of Conventional Therapies and Intervention with Nucleic acid-Based Therapaeutics. Chem. Rev. 2015, 115, 4719–4743. DOI: 10.1021/cr5002832.
   PubMed Web of Science ®Google Scholar
• Monika, A.; Kowiel, L.; Muszalska, I. Strategies in the Designing of Prodrugs, Taking into account the Antiviral and Anticancer Compounds. Eur. J. Med. Chem. 2017, 129, 53–71. DOI: 10.1016/j.ejmech.2017.02.011.
   PubMed Web of Science ®Google Scholar
• Huttunen, K. M.; Leppanen, J.; Laine, K.; Vepsalainen, J.; Rautio, J. Convenient Microwave-Assisted Synthesis of Lipophilic Sulfonamide Prodrugs of Metformin. Eur. J. Pharm. Sci. 2013, 49, 624–628. DOI: 10.1016/j.ejps.2013.05.023.
   PubMed Web of Science ®Google Scholar
• Dandona, P.; Fonseca, V.; Mier, A.; Beckett, A. G. Diarrhea and Metformin in a Diabetic Clinic. Diabetes Care 1983, 6, 472–474. DOI: 10.2337/diacare.6.5.472.
   PubMed Web of Science ®Google Scholar
• Huttunen, K. M.; Mannila, A.; Laine, K.; Kemppainen, E.; Leppänen, J.; Vepsäläinen, J.; Järvinen, T.; Rautio, J. The First Bioreversible Prodrug of Metformin with Improved Lipophilicity and Enhanced Intestinal Absorption. J. Med. Chem. 2009, 52, 4142–4148. DOI: 10.1021/jm900274q.
   PubMed Web of Science ®Google Scholar
• Takahashi, M.; Ogawa, T.; Kashiwagi, H.; Fukushima, F.; Yoshitsugu, M.; Haba, M.; Hosokawa, M. Chemical Synthesis of an Indomethacin Ester Prodrug and Its Metabolic Activation by Human Carboxylesterase. Bioorg. Med. Chem. Lett. 2018, 28, 997–1000. DOI: 10.1016/j.bmcl.2018.02.035.
   PubMed Web of Science ®Google Scholar
• Bora, U.; Saikia, A.; Boruah, R. C. A Novel Microwave-Mediated One-Pot Synthesis of Indolizines via a Three-Component Reaction. Org. Lett. 2003, 5, 435–438. DOI: 10.1021/ol020238n.
   PubMed Web of Science ®Google Scholar
• Albaladejo, M. J.; Gonzalez-Soria, M. J.; Alonso, F. Synthesis of Aminoindolizidines through the Chemo Selective and Diasteroselective Catalytic Hydrogenation of Indolizine. J. Org. Chem. 2016, 81, 9707–9717. DOI: 10.1021/acs.joc.6b01782.
   PubMed Web of Science ®Google Scholar
• Singh, S. B.; Rindgen, D.; Bradley, P.; Suzuki, T.; Wang, N.; Wu, H.; Zhang, B.; Wang, L. C.; Ji, Y. H.; Soll, R. M.; et al. Design, Synthesis, Structure-Function Relationship, Bioconversion, and Pharmacokinetic Evaluation of Etrapenem Prodrugs. J. Med. Chem. 2014, 57, 8421–8444. DOI: 10.1021/jm500879a.
   PubMed Web of Science ®Google Scholar
• Das, N.; Dhanawat, M.; Dash, B.; Nagarwal, R. C.; Shrivastava, S. K. Co-Drug: An Efficient Approach for Drug Optimization. Eur. J. Pharm. Sci. 2010, 41, 571–588. DOI: 10.1016/j.ejps.2010.09.014.
   PubMed Web of Science ®Google Scholar
• Orioli, M.; Vistoli, G.; Regazzoni, L.; Pedretti, A.; Lapolla, A.; Rossoni, G.; Canevotti, R.; Gamberoni, L.; Previtali, M.; Carini, M.; Aldini, G. Design, Synthesis, ADME Properties, and Pharmacological Activities of b-Alanyl-d-Histidine (d-Carnosine) Prodrugs with Improved Bioavailability. Chem. Med. Chem. 2011, 6, 1269–1282. DOI: 10.1002/cmdc.201100042.
   Google Scholar
• Rivault, F.; Opalinski, I. T.; Gesson, J. P. A New Linker for Glucoronylated Anticancer Prodrugs. Bioorg. Med. Chem. 2004, 12, 675–682. DOI: 10.1016/j.bmc.2003.11.026.
   PubMed Web of Science ®Google Scholar
• Bender, D. M.; Peterson, J. A.; McCarthy, J. R.; Gunaydin, H.; Takano, Y.; Houk, K. N. Cyclopropanecarboxylic Acid Esters as Potential Prodrugs with Enhanced Hydrolytic Stability. Org. Lett. 2008, 10, 509–511. DOI: 10.1021/ol702892e.
   PubMed Web of Science ®Google Scholar
• Mariappan, G.; Saha, B. P.; Datta, S.; Kumar, D.; Haldar, P. K. Design, Synthesis and Antidiabetic Evaluation of Oxazolone Derivatives. J. Chem. Sci. 2011, 123, 335–341. DOI: 10.1007/s12039-011-0079-2.
   Web of Science ®Google Scholar
• Owu, D. U.; Antai, A. B.; Udofia, K. H.; Obembe, A. O.; Obasi, K. O.; Eteng, M. U. Vitamin C Improves Basal Metabolic Rate and Lipid Profile in Alloxan-Induced Diabetes Mellitus in Rats. J. Biosci. 2006, 31, 575–579. DOI: 10.1007/BF02708409.
   PubMed Web of Science ®Google Scholar
• Tatipamula, V. B.; Kolli, M. K.; Lagu, S. B.; Paidi, K. R.; P, R. R.; Yejella, R. P. Novel Indolizine Derivatives Lowers Blood Glucose Levels in Streptozotocin-Induced Diabetic Rats: A Histopathological Approach. Pharmacol. Rep. 2019, 71, 233–242. DOI: 10.1016/j.pharep.2018.11.004.
   PubMed Web of Science ®Google Scholar
• Kapoor, G.; Pathak, D. P.; Bhutani, R.; Husain, A.; Jain, S.; Iqbal, M. A. Synthesis ADME, Docking Studies and in Vivo Anti-Hyperglycemic Potential Estimation of Novel Schiff Base Derivatives from Octadec-9-Enoic Acid. Bioorg. Chem. 2019, 84, 478–492. DOI: 10.1016/j.bioorg.2018.12.004.
   PubMed Web of Science ®Google Scholar
• Nandini, H. S.; Naik, P. R. Antidiabetic, Antihyperlipidemic and Antioxidant Effect of Vincamine, in Streptozotocin-Induced Diabetic Rats. Eur. J. Pharmacol. 2019, 843, 233–239. DOI: 10.1016/j.ejphar.2018.11.034.
   PubMed Web of Science ®Google Scholar
• Sayeli, V. K.; Shenoy, A. K. Antidiabetic Effect of Bio-Enhanced Preparation of Turmeric in Streptozotocin-Nicotinamide Induced Type 2 Diabetic Wistar Rats. J. Ayurveda Integr. Med. 2021, 12, 474–479. DOI: 10.1016/j.jaim.2021.04.010.
   PubMed Web of Science ®Google Scholar
• Huttunen, K. M.; Rautio, J.; Leppänen, J.; Vepsäläinen, J.; Keski-Rahkonen, P. Determination of Metformin and Its Prodrugs in Human and Rat Blood by Hydrophilic Interaction Liquid Chromatography. J. Pharm. Biomed. Anal. 2009, 50, 469–474. DOI: 10.1016/j.jpba.2009.04.033.
   PubMed Web of Science ®Google Scholar
• Kaur, J.; Bhardwaj, A.; Huang, Z.; Narang, D.; Chen, T.,Y.; Plane, F.; Knaus, E.,E. Synthesis and Biological Investigations of Nitric Oxide Releasing Nateglinide and Meglitinide Type II Antidiabetic Prodrugs: In-Vivo Antihyperglycemic Activities and Blood Pressure Loweing Studies. J. Med. Chem. 2012, 55, 7883–7891. DOI: 10.1021/jm300997w.
   PubMed Web of Science ®Google Scholar
• Abbas, S. Y.; Basyouni, W. M.; Khairy, A. M.; El-Bayouk, W. L.; Tohamy, H.; Aly, F.; Arafa, A.; Soliman, M.,S. New Bigauanides as anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as anti-Diabetic Agents of Type II Diabetes Insulin Resistant. Drug Res. (Stuttg) 2017, 67, 557–563. DOI: 10.1055/s-0043-102692.
   PubMed Web of Science ®Google Scholar